Lilly(Eli) & Co

Obesity, oncology and old age: How 2023 pharmaceutical M&A is reshaping the health-care industry

3 Growth Stock Picks That Still Have Room to Grow

A Look at Pharma M&A — Consolidating Strengths In Oncology, Immunology and More

Thinking About Stock Prices? Don’t Forget Sector Weights, Seasonality, Commodities

Big Pharma and The Need for Speed

Could Investors Overdose on Pharmaceuticals?